Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing biases and limitations in feature attribution for circRNA modification profiling.

Briefings in bioinformatics·2026
Same author

Beyond Parametric Assumptions: Unsupervised Methods Enhance DNA Repair Gene Discovery in <i>SMARCAL1</i> Identification.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Beyond linear assumptions in pulmonary function analysis: a methodological critique of veteran health outcome models.

Annals of the American Thoracic Society·2026
Same author

Revisiting AI Interpretability in Precision Oncology: Why Predictive Accuracy Does Not Ensure Stable Feature Importance.

Cancers·2026
Same author

The Diagnostic Trap in Radiation-Induced Mesothelioma: Kinetic-Morphological Decoupling Masks Molecular Aggression.

Cancers·2026
Same author

Correspondence: Accuracy Is Not Enough: Stability-Aware Feature Selection for Reproducible Biomarker Discovery.

Allergy·2025

Related Experiment Video

Updated: Jul 8, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K

Artificial intelligence universal biomarker prediction tool.

Yoshiyasu Takefuji1

  • 1Faculty of Data Science, Musashino University, 3-3-3 Ariake Koto-ku, Tokyo, 135-8181, Japan. takefuji@keio.jp.

Journal of Thrombosis and Thrombolysis
|December 20, 2023
PubMed
Summary

An artificial intelligence tool predicts disease progression using biomarkers like HbA1c for diabetes and NT-proBNP for heart failure. This AI biomarker prediction aims to help patients understand and anticipate future healthcare needs.

Keywords:
Cardiopulmonary arrestMedication and exercisehbA1c and NT-proBNP

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Related Experiment Videos

Last Updated: Jul 8, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Area of Science:

  • Biomedical Informatics
  • Artificial Intelligence in Healthcare
  • Predictive Analytics

Background:

  • Cardiopulmonary arrest events can signify critical health junctures.
  • Biomarkers such as HbA1c (glycated hemoglobin) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) are crucial indicators for diabetes and heart failure, respectively.
  • Predictive modeling offers a pathway to proactively manage chronic conditions.

Discussion:

  • The developed AI tool integrates HbA1c and NT-proBNP levels to forecast future hospital visits.
  • This predictive capability empowers patients with a clearer understanding of their disease trajectory.
  • The tool's foundation in real-world patient data, including those experiencing cardiopulmonary arrest, enhances its clinical relevance.

Key Insights:

  • An AI-driven predictive tool has been created to monitor disease trends using key biomarkers.
  • The system forecasts subsequent hospital admissions, aiding patient comprehension of their health status.
  • This approach offers a novel method for personalized disease management and patient engagement.

Outlook:

  • Future iterations could incorporate additional biomarkers for broader disease prediction.
  • Expansion of the AI tool to other chronic conditions is a potential development.
  • Enhanced patient understanding of disease trends can lead to improved adherence and outcomes.